- Home
- WFG vs STVN Comparison
WFG vs STVN Comparison
Compare WFG & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- STVN
- Stock Information
- Founded
- WFG 1955
- STVN 1949
- Country
- WFG Canada
- STVN Italy
- Employees
- WFG N/A
- STVN N/A
- Industry
- WFG
- STVN Containers/Packaging
- Sector
- WFG
- STVN Consumer Discretionary
- Exchange
- WFG Nasdaq
- STVN Nasdaq
- Market Cap
- WFG 7.5B
- STVN 6.2B
- IPO Year
- WFG N/A
- STVN 2021
- Fundamental
- Price
- WFG $87.80
- STVN $23.67
- Analyst Decision
- WFG Buy
- STVN Buy
- Analyst Count
- WFG 4
- STVN 6
- Target Price
- WFG $106.25
- STVN $27.50
- AVG Volume (30 Days)
- WFG 144.8K
- STVN 343.4K
- Earning Date
- WFG 02-12-2025
- STVN 11-05-2024
- Dividend Yield
- WFG 1.46%
- STVN 0.24%
- EPS Growth
- WFG N/A
- STVN N/A
- EPS
- WFG N/A
- STVN 0.48
- Revenue
- WFG $6,283,000,000.00
- STVN $1,220,254,294.00
- Revenue This Year
- WFG N/A
- STVN $3.01
- Revenue Next Year
- WFG $6.67
- STVN $7.16
- P/E Ratio
- WFG N/A
- STVN $49.11
- Revenue Growth
- WFG N/A
- STVN 3.53
- 52 Week Low
- WFG $73.91
- STVN $16.56
- 52 Week High
- WFG $102.40
- STVN $34.73
- Technical
- Relative Strength Index (RSI)
- WFG 33.10
- STVN 77.49
- Support Level
- WFG $91.92
- STVN $19.25
- Resistance Level
- WFG $94.18
- STVN $24.90
- Average True Range (ATR)
- WFG 2.27
- STVN 1.02
- MACD
- WFG -0.87
- STVN 0.38
- Stochastic Oscillator
- WFG 11.28
- STVN 78.23
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board, or OSB, producers in the world.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.